Related Articles
Mechanisms underlying resistance to cetuximab in the HNSCC cell line: Role of AKT inhibition in bypassing this resistance
Selective inhibition of PI3K110α as a novel therapeutic strategy for cetuximab‑resistant oral squamous cell carcinoma
Predicting resistance to endocrine therapy in breast cancer: It's time for epigenetic biomarkers (Review)
Mechanisms of gram‑positive vancomycin resistance (Review)
Does dexamethasone inhibit anticancer activity of cetuximab in squamous cell carcinoma cell lines of the head and neck?